Sign In
Buy PETS
$1.95
-0.0300 (-1.52%)
At Close: Jul 31, 2026
This Dividend Aristocrat's High Yield Looks Like a Safe Haven
12:28pm, Tuesday, 29'th Nov 2022
Investors shopping for income often begin by asking if a dividend, and particularly a high one, is sustainable. It's a logical and important question every investor should ask.
PetMed Express, Inc. (PETS) Q2 2022 Earnings Call Transcript
08:40pm, Monday, 07'th Nov 2022
Start Time: 16:30 January 1, 0000 5:04 PM ET PetMed Express, Inc. (NASDAQ:PETS ) Q2 2022 Earnings Conference Call November 07, 2022, 16:30 PM ET Company Participants Matthew Hulett - President and CEO
3 Small-Cap Dividend Stocks With Strong Yields
02:46pm, Monday, 07'th Nov 2022
Income-focused investors often target the largest companies, as those with lengthy track records of dividend growth are usually the leaders within their area of the economy. Still, investors could do
November Retail Sales Steady: 3 ETF & Stock Picks
08:17am, Tuesday, 01'st Nov 2022
3 ETF and stocks to play the surge in retail sales in November.
FAZE, PETS: The Top 5 Short Squeeze Stocks to Watch This Week
12:39pm, Tuesday, 06'th Sep 2022
Source: Piotr Swat / Shutterstock.com We're covering the top short squeeze stocks of the week that traders are going to want to keep an eye on. These short squeeze stocks come Fintel's Short Squeeze L
PetMed Express, Inc. (PETS) CEO Matthew Hulett on Q1 2022 Results - Earnings Call Transcript
10:42pm, Monday, 25'th Jul 2022
PetMed Express, Inc. (NASDAQ:PETS ) Q1 2022 Earnings Conference Call July 25, 2022 4:30 PM ET Corporate Participants Matthew Hulett - President and Chief Executive Officer Bruce Rosenbloom - Chief Fin
PetMed (PETS) Q1 Earnings and Revenues Lag Estimates
06:35pm, Monday, 25'th Jul 2022
PetMed (PETS) delivered earnings and revenue surprises of -46.15% and 13.03%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Two Pet Health Stocks To Watch And One To Avoid
04:00am, Tuesday, 05'th Jul 2022
Growth stocks have been getting pummeled this year due to fears of slowing growth, tightening margins, and recession but in some cases, the baby is getting tossed out with the bathwater. In this case,
Is This Small Cap Stock's Dividend Yield Worth the Price?
08:03am, Tuesday, 07'th Jun 2022
PetMed Express, Inc. (NASDAQ:PETS) is an online pet pharmacy based in the U.S. that is licensed to dispense prescription medications in all 50 states.
7 Dividend Stocks to Buy for June With Yields Over 6%
06:45am, Sunday, 29'th May 2022
As the stock market plunges toward bear market territory, investors increasingly look for dividend stocks to buy. These are the best dividend stocks to buy now.
PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth
10:36am, Thursday, 26'th May 2022
We analyzed its AutoShip & Save program which was introduced in 2021 and expect it to contribute to higher recurring revenue with higher reorder sales as a percentage of revenue. Additionally, we beli
PetMed quarterly sales suffer from slow start to flea-and-tick season but subscription business grows
12:32pm, Tuesday, 10'th May 2022
PetMed Express Inc. PETS, +6.44% says its fiscal fourth-quarter sales suffered from a slow start to the flea-and-tick season, but the company expects that part of the business to bounce back as the wa
If PetMeds Is A Good Buy There Will Be A Better Signal
11:44am, Tuesday, 10'th May 2022
Shares of PetMeds (NASDAQ: PETS) are rocketing higher in the wake of what we can only call a mixed report. The news wasn't bad and it wasn't good and it certainly isn't enough to have shares up by 9%,
Petmed Express, Inc. (PETS) CEO Matthew Hulett on Q4 2021 Results - Earnings Call Transcript
09:45pm, Monday, 09'th May 2022
Petmed Express, Inc. (NASDAQ:PETS ) Q4 2021 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Bruce Rosenbloom - CFO & Treasurer Matthew Hulett - CEO, President & Director Conferenc
PetMed (PETS) Q4 Earnings Top Estimates
06:48pm, Monday, 09'th May 2022
PetMed (PETS) delivered earnings and revenue surprises of 11.11% and 2.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
